KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Enterprise Value: 2010-2015

Historic Enterprise Value for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $764.6 million.

  • Biocryst Pharmaceuticals' Enterprise Value rose 33.06% to $764.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was $529.9 million, marking a year-over-year increase of 42.04%. This contributed to the annual value of $801.1 million for FY2014, which is 94.89% up from last year.
  • Biocryst Pharmaceuticals' Enterprise Value amounted to $764.6 million in Q3 2015, which was down 22.64% from $988.4 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' Enterprise Value's 5-year high stood at $988.4 million during Q2 2015, with a 5-year trough of -$31.3 million in Q1 2011.
  • Moreover, its 3-year median value for Enterprise Value was $585.5 million (2015), whereas its average is $528.8 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 74.43% in 2013, then spiked by 1,203.28% in 2014.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Enterprise Value stood at $70.0 million in 2011, then plummeted by 47.61% to $36.7 million in 2012, then soared by 1,021.52% to $411.0 million in 2013, then spiked by 94.89% to $801.1 million in 2014, then soared by 33.06% to $764.6 million in 2015.
  • Its Enterprise Value was $764.6 million in Q3 2015, compared to $988.4 million in Q2 2015 and $585.5 million in Q1 2015.